Ligand Pharmaceuticals (LGND) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Ligand Pharmaceuticals (LGND) over the last 16 years, with Q3 2025 value amounting to $60.36.
- Ligand Pharmaceuticals' Times Interest Earned rose 132314.76% to $60.36 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6, marking a year-over-year increase of 16420.01%. This contributed to the annual value of -$7.44 for FY2024, which is 14088.89% down from last year.
- Latest data reveals that Ligand Pharmaceuticals reported Times Interest Earned of $60.36 as of Q3 2025, which was up 132314.76% from $7.32 recorded in Q2 2025.
- Over the past 5 years, Ligand Pharmaceuticals' Times Interest Earned peaked at $3078.0 during Q3 2023, and registered a low of -$83.75 during Q4 2022.
- Moreover, its 5-year median value for Times Interest Earned was $4.24 (2024), whereas its average is $164.63.
- In the last 5 years, Ligand Pharmaceuticals' Times Interest Earned tumbled by 109210.7% in 2022 and then soared by 818049.59% in 2023.
- Quarter analysis of 5 years shows Ligand Pharmaceuticals' Times Interest Earned stood at $8.44 in 2021, then plummeted by 1092.11% to -$83.75 in 2022, then soared by 69.39% to -$25.63 in 2023, then surged by 57.42% to -$10.91 in 2024, then skyrocketed by 653.09% to $60.36 in 2025.
- Its Times Interest Earned was $60.36 in Q3 2025, compared to $7.32 in Q2 2025 and -$41.77 in Q1 2025.